Lugol's Solution Reduces Positive Margins and Residual Disease After the Large Loop Excision of Transformation Zone.
Min-Jeong KimGrace J LeeEun Ji LeeSeungmee LeeDoo Byung ChayChae Hyeong LeeJae-Hoon KimJu-Won RohPublished in: Journal of lower genital tract disease (2023)
Lugol's solution optimizes CIN treatment by reducing the proportion of positive RMs and residual disease after LLETZ.
Keyphrases